1. Home
  2. CPIX vs BNR Comparison

CPIX vs BNR Comparison

Compare CPIX & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • BNR
  • Stock Information
  • Founded
  • CPIX 1999
  • BNR 2014
  • Country
  • CPIX United States
  • BNR China
  • Employees
  • CPIX N/A
  • BNR N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • BNR Medical Specialities
  • Sector
  • CPIX Health Care
  • BNR Health Care
  • Exchange
  • CPIX Nasdaq
  • BNR Nasdaq
  • Market Cap
  • CPIX 40.1M
  • BNR 38.3M
  • IPO Year
  • CPIX 2009
  • BNR 2020
  • Fundamental
  • Price
  • CPIX $3.44
  • BNR $6.47
  • Analyst Decision
  • CPIX
  • BNR
  • Analyst Count
  • CPIX 0
  • BNR 0
  • Target Price
  • CPIX N/A
  • BNR N/A
  • AVG Volume (30 Days)
  • CPIX 81.2K
  • BNR 53.8K
  • Earning Date
  • CPIX 08-05-2025
  • BNR 08-21-2025
  • Dividend Yield
  • CPIX N/A
  • BNR N/A
  • EPS Growth
  • CPIX N/A
  • BNR N/A
  • EPS
  • CPIX N/A
  • BNR N/A
  • Revenue
  • CPIX $41,083,299.00
  • BNR $72,112,038.00
  • Revenue This Year
  • CPIX N/A
  • BNR $136.32
  • Revenue Next Year
  • CPIX N/A
  • BNR N/A
  • P/E Ratio
  • CPIX N/A
  • BNR N/A
  • Revenue Growth
  • CPIX 5.82
  • BNR 0.53
  • 52 Week Low
  • CPIX $1.04
  • BNR $2.18
  • 52 Week High
  • CPIX $7.25
  • BNR $9.48
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 46.28
  • BNR 60.79
  • Support Level
  • CPIX $3.25
  • BNR $5.81
  • Resistance Level
  • CPIX $3.97
  • BNR $9.48
  • Average True Range (ATR)
  • CPIX 0.36
  • BNR 0.90
  • MACD
  • CPIX 0.07
  • BNR 0.12
  • Stochastic Oscillator
  • CPIX 45.36
  • BNR 45.86

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: